Gastroesophageal junction adenocarcinoma on esophagogastroduodenoscopy biopsy. Initial PET-CT showed no definite evidence of distant metastatic disease. One month after radiation treatment, repeat PET-CT showed interval decrease in size of gastroesophageal mass but new multifocal FDG avidity in the caudate and left hepatic lobes. Correlation with contrast-enhanced CT and US images was negative, making metastasis less likely. Ultrasound-guided biopsy confirmed radiation-induced hepatitis, which caused false positively increased FDG uptake from inflammatory changes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/RLU.0000000000001404 | DOI Listing |
Clin Nucl Med
January 2017
From the *Diagnostic Radiology, Allegheny General Hospital, Pittsburgh, PA; and †Diagnostic Radiology, Stony Brook University, Stony Brook, NY; ‡Family Medicine and §Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA.
Ann Nucl Med
January 2013
Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, 21201, USA.
Purpose: Treatment effect of radiofrequency ablation (RFA) is traditionally accomplished with MRI and/or CT. The aim of the study was to assess the role of FDG-PET in post RFA hepatic tumor evaluation, in comparison with MRI and CT.
Materials And Methods: 28 patients (33 hepatic RFA lesions) who had post RFA FDG-PET within 8 weeks of abdominopelvic MRI or CT were retrospectively reviewed.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!